A breast cancer vaccine targeting the most aggressive form of the disease is in early clinical trials. Phase one studies currently have shown no significant side effects. NTD’s Jason Blair brings us more.
Breast Cancer Vaccine In Early Trials
By Jason Blair
Sign up for NTD Daily
What you need to know, summarized in one email.
Stay informed with accurate news you can trust.
Stay informed with accurate news you can trust.
Success! You are now subscribed.
By registering for the newsletter, you agree to the Privacy Policy.